Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
18 Cards in this Set
- Front
- Back
T Cell Suppressants
|
Mechanism: either block the calcineurin (NFAT) pathway or the PKC pathway of gene expression
Cyclosporine A(Sandimmune) Tacrolimus (Prograf) Sirolimus (Rapamune/rapamycin) Abatacept (Orencia) |
|
Cyclosporine A
(Sandimmune) |
T cell suppressant
calcineurin inhibitor (at an intracellular receptor cyclophilin)- blocks the activation of T cells via blocking NFAT gene expression Side Effects- renal, HTN, overgrowth of gum tissues |
|
Tacrolimus (Prograf)- FK506
|
T cell Suppressant
calcineurin inhibitor (by binding a different intracellular receptor FKBP12)- blocks the activation of T cells via blocking NFAT gene expression Side Effects- renal, HTN, overgrowth of gum tissues |
|
Sirolimus (Rapamune/ rapamycin)
|
T-Cell Suppressant
binds FKBP12 (like Tacrolimus) but acts as an mTOR inhibitor to decreases DNA synthesis and cell proliferation in response to cytokines binding their receptors-interrupts cytokine signaling in B- and T-cells. |
|
Abatacept (Orencia)
|
T- cell suppressor- but used for rheumatoid arthritis, not for organ transplantation
a homologue of CD28- binds CD80 or CD86 to interrupt the costimulatory signal and block T-cell activation- results in T-cell Anergy |
|
Antibody Reagents
|
Uses-
1. Prior to transplantation to deplete certain cell populations that could mount a rejection response to a transplanted organ (Atgam, OKT3) 2. Acute rejection in somebody already immunosuppressed on the triple regimen (Daclizumab) 3. To prevent hemolytic disease of the newborn (RhoGAM) Antithymocyte globulin (Atgam) Muromonab-CD3 (OKT3) Daclizumab (Zenapax) Rho(D)Ig (RhoGAM) |
|
Antithymocyte globulin (Atgam)
|
Antibody derived from horses injected with human lymphocytes- purified IgG is isolated and injected into the patient to deplete T cells very rapidly
|
|
Muromonab-CD3 (OKT3)
|
Mouse monoclonal antibody that specifically targets the CD3 molecule on the helper T cell- as a big molecule, it can prevent interaction between helper T cells and APCs, but most importantly induces lysis of helper T cells
|
|
Daclizumab (Zenapax)
|
Antibody against the IL-2 receptor thereby blocking IL-2 from meeting its target on the CD8 cell- blocks downstream signaling.
Used for acute rejection episodes |
|
Rho(D)Ig (RhoGAM)
|
Human product isolated from the serum of people with antibodies against the Rh antigen- given to Rh- women during pregnancy to prevent sensitization- does not cause lysis of those cells, just coats them to block their interaction with APCs
Used to prevent Hemolytic disease of newborn (+ kid with - mom) |
|
Cytotoxic Drugs
|
interfere with the metabolism of nucleic acids- prevents clonal expansion of T and B cells
Mycophenolate mofetil (Celicept) Azathioprine(Imuran) also used (at higher doses) in cancer chemotherapy to kill rapidly dividing cells |
|
Azathioprine (Imuran)
|
Cytotoxic
a pro-drug and is metabolized to mercaptopurine- Its metabolite is incorporated into the DNA strand during replication- it is bulky and stalls the DNA polymerase to interrupt chain elongation |
|
Mycophenolate mofetil (Celicept)
|
Cytotoxic
a pro-drug that is metabolized to mycophenolic acid- the enzyme (IMP dehydrogenase) inhibitor that prevents the production of one of the nucleotides vital to DNA synthesis. *Lymphocytes are more reliant on the de novo pathway than they are on the salvage pathway- drug specificity for immune cells over other rapidly proliferating cells |
|
Glucocorticoids
|
multiple sites of action via binding of steroid receptors to initiate transcription of I_B (the inhibitory subunit of NF-_B):
1. Prevent lymphocyte trafficking by blocking adhesion 2. Inhibit T cell proliferation 3. Inhibit expression of cytokines 4. Inhibit macrophage and lymphocyte function Prednisone(Prednisolone) Methylprednisolone |
|
Methylprednisolone
|
Glucocorticoid
|
|
Prednisone (Prednisolone)
|
Glucocorticoid
prevents lymphocyte tracking by blocking the adhesion of lymphocytes to the endothelium in order to leave the circulatory system |
|
Risks of long term immunosupression
|
Immediate risk of infection
Long-term risk of malignancy |
|
Organ transplants regimen
|
triple regimen:
T-cell suppressant a cytotoxic drug a glucocorticoid antibody agents are used pre-transplant to prepare the immune system |